Hilton Capital Management, LLC Bristol Myers Squibb CO Transaction History

Hilton Capital Management, LLC

$1.16 Billion
Q2 2024

A detailed history of Hilton Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hilton Capital Management, LLC holds 6,220 shares of BMY stock, worth $321,885. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,220

Previous 6,220 -0.0%

Holding current value

$321,885

Previous $337,000 23.44%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $6,371 - $7,073	-100 Reduced 1.58%	6,220 $397,000
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $41,725 - $47,326	-635 Reduced 9.13%	6,320 $438,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $20,559 - $12.2 Million	-158,148 Reduced 95.79%	6,955 $494,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $11.3 Million - $12.5 Million	155,719 Added 1659.41%	165,103 $12.7 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $64,492 - $77,332	1,049 Added 12.59%	9,384 $685,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $5,845 - $6,814	109 Added 1.33%	8,335 $520,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $28,934 - $33,892	-489 Reduced 5.61%	8,226 $486,000
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $185 - $202	3 Added 0.03%	8,715 $582,000
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $15,428 - $17,352	260 Added 3.08%	8,712 $550,000
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $8,430 - $9,552	-146 Reduced 1.7%	8,452 $524,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $9,303 - $10,309	162 Added 1.92%	8,598 $518,000
Q2 2020 Jul 14, 2020	SELL	$54.82 - $64.09 $22,805 - $26,661	-416 Reduced 4.7%	8,436 $496,000
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $3,433 - $4,989	74 Added 0.84%	8,852 $493,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $305,840 - $398,940	6,215 Added 242.49%	8,778 $563,000
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $29,425 - $34,888	688 Added 36.69%	2,563 $130,000
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $3,203 - $3,819	71 Added 3.94%	1,875 $89,000
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $21,844 - $28,327	448 Added 33.04%	1,804 $94,000
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $1,655 - $1,867	-30 Reduced 2.16%	1,356 $84,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $70,034 - $87,290	1,386 New	1,386 $77,000

Others Institutions Holding BMY

# of Institutions

2,402

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hilton Capital Management, LLC with notifications on news.

Account

Hilton Capital Management, LLC Bristol Myers Squibb CO Transaction History